Degao Chen
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
- Cancer-related Molecular Pathways 2
- Immunology 10
- Immune cells in cancer 6
- Immune Cell Function and Interaction 4
- Co-authors
- Bo Zhu (4 shared papers)Xiaomei Zhang (1 shared paper)Zhongjun Li (1 shared paper)Bo Zhu (1 shared paper)Jingwei Ma (9 shared papers)Wenqian Dong (7 shared papers)Xiaoyu Liang (8 shared papers)Ke Tang (8 shared papers)
- Journals
- OncoImmunology (3 papers)Biomaterials (2 papers)Nature Cell Biology (2 papers)Cellular and Molecular Life Sciences (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Degao Chen
20 papers receiving 1.8k citations
Degao Chen's Hit Papers
Peers
Comparison fields: 5 of 93
- Immunology 737
- Cancer Research 305
- Oncology 407
- Molecular Biology 790
- Physiology 38
Countries citing papers authored by Degao Chen
This map shows the geographic impact of Degao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Degao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Degao Chen more than expected).
Fields of papers citing papers by Degao Chen
This network shows the impact of papers produced by Degao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Degao Chen. The network helps show where Degao Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Degao Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype Hit paper breakdown → | 2018 | 395 |
| 2 | 2020 | 282 | |
| 3 | Type I interferon-mediated tumor immunity and its role in immunotherapy Hit paper breakdown → | 2022 | 208 |
| 4 | 2017 | 160 | |
| 5 | 2016 | 104 | |
| 6 | 2018 | 92 | |
| 7 | 1994 | 91 | |
| 8 | 2016 | 87 | |
| 9 | 2019 | 67 | |
| 10 | 2020 | 64 | |
| 11 | 2018 | 51 | |
| 12 | 2018 | 51 | |
| 13 | 2017 | 31 | |
| 14 | 2017 | 31 | |
| 15 | 2016 | 29 | |
| 16 | 2015 | 25 | |
| 17 | 2016 | 14 | |
| 18 | 2023 | 8 | |
| 19 | 2024 | 4 | |
| 20 | 2025 | 1 |
About Degao Chen
Degao Chen is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Hematology, having authored 22 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immune cells in cancer (6 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers), Extracellular vesicles in disease (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer-related Molecular Pathways (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Immunology (737 citations), Cancer Research (305 citations), Oncology (407 citations), Molecular Biology (790 citations) and Physiology (38 citations). Degao Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Bo Zhu, Xiaomei Zhang, Zhongjun Li, Bo Zhu, Jingwei Ma, Wenqian Dong, Xiaoyu Liang, Ke Tang, Yuying Liu and Bo Huang. Their work appears in journals such as OncoImmunology, Biomaterials, Nature Cell Biology, Cellular and Molecular Life Sciences and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.